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INTRODUCTION
Although its incidence varies, gastric cancer is the 
fourth-most prevalent cancer and the second-most 
common cause of cancer-related deaths worldwide 
(1). Intestinal-type gastric cancer, the most common 
subtype, is thought to develop by the carcinogen-
esis cascade defined by Correa (2). In this model, the 
progression of chronic gastritis is a multistep process 
of atrophy, intestinal metaplasia (IM), and dysplasia, 
which may lead to invasive carcinoma (2). Despite ag-
gressive and expensive treatments, most patients with 
gastric adenocarcinoma die during the first year due to 
delayed diagnosis. Therefore, the early treatment and 
follow-up of patients with precancerous lesions, includ-
ing IM and chronic atrophic gastritis, is important (3).
Although guidelines exist for some conditions, such as 
Barrett’s esophagus, ulcerative colitis, and colonic pol-
yps, there are no clear recommendations for gastric IM, 
a precancerous gastric lesion. The 2006 American Soci-
ety for Gastrointestinal Endoscopy guidelines reported 
that most patients in the United States had a low risk 
of cancer progression; therefore, endoscopic surveil-
lance for IM was not indicated for average-risk patients 
(4). According to the 2012 European Society of Gastro-
intestinal Endoscopy guidelines, patients with extensive 
atrophy and metaplasia should be followed up every 3 
years (5). However, there are disagreements over the rec-
ommended follow-up of IM limited to the antrum and 
3-year follow-up interval for extensive metaplasia (6).
Helicobacter pylori infection is a major risk factor for 
the development of gastric IM. A number of studies 
have reported an association of H. pylori infection with 
pathogenesis of colonic polyps and colorectal cancer 
(CRC). This infection is thought to increase the frequen-
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Background/Aims: Chronic gastritis progression is a multistep process of atrophy, intestinal metaplasia (IM), 
and dysplasia, which may lead to invasive carcinoma. In this study, we identified an association of colonic pol-
yps with gastric IM in patients undergoing colonoscopy.
Materials and Methods: This retrospective case-control, cross-sectional study was conducted in a tertiary-care 
institution in Turkey. Pathology and endoscopy reports were reviewed. The study group comprised 400 patients 
with colonic adenomatous polyps, and the control group comprised 360 patients without colonic adenoma-
tous polyps on colonoscopy.
Results: The risk of gastric IM was 1.42-fold higher in the study group (p<0.05). The risk of IM in patients aged 
≥50 years with colonic polyps was 3.35-fold higher than in those aged <50 years (p<0.05). The risk of Helico-
bacter pylori infection in the study group was 1.07-folder higher than that in the control group (p<0.05). H. pylori 
infection prevalence was higher only in patients with high-grade colonic polyp dysplasia (p<0.05). There were 
no statistically significant differences in the proportion of incomplete IM between the groups (p<0.05).
Conclusion: This study observed increased rates of gastric IM with colonic polyps. An increased risk of gastric 
IM was associated with higher grades of polyp dysplasia. 
Keywords: Helicobacter pylori, intestinal metaplasia, colonic polyps, dysplasia
cy of colonic polyps and CRC. The effect of H. pylori infection 
on colonic polyps and CRC has been investigated in patients 
undergoing gastroscopy. In this study, we identified an asso-
ciation of colonic polyps with gastric IM in patients undergo-
ing colonoscopy and determined if the location or number of 
colonic polyps or the presence of polyp dysplasia can be used 
to gastric atrophy or gastric IM.
MATERIALS AND METHODS
Data collection
This retrospective case-control, cross-sectional study was con-
ducted at Başkent University Medical and Research Center, a 
tertiary-care institution in Konya, Turkey. Patient pathology and 
endoscopy reports from January 1, 2010 to December 31, 2013 
were reviewed from the electronic database. We analyzed data 
of 1,475 patients over 18 years of age who underwent gastros-
copy and colonoscopy on the same day at the gastroenterol-
ogy clinic. Indications for gastrointestinal endoscopy included 
chronic diarrhea (10%), CRC screening (12%), weight loss (18%), 
anemia (22%), melena (4%), abdominal pain (21%), abdominal 
bloating (10%), and a positive fecal occult blood test (3%). Four 
gastroenterologists who had received the same gastroenterol-
ogy fellowship training performed all endoscopies (Evis Exera II 
system, CLV-180, Olympus, Inc.; Tokyo, Japan).
We excluded 220 patients with inflammatory bowel disease, 
237 without antrum or incisura biopsies, 98 with gastric can-
cer or CRC, 102 with inadequate bowel preparation, 38 with 
unsuccessful cecal intubation, and 20 with hyperplastic polyps.
Of the remaining 760 patients, demographic data and the pres-
ence of H. pylori infection, gastric atrophy, or IM were evaluated 
in antrum and incisura biopsy specimens. The study group 
comprised 400 patients with colonic adenomatous polyps, and 
the control group comprised 360 patients without polyps on 
colonoscopy. Patient selection is depicted in Figure 1.
Antrum and incisura biopsies were stained using hematoxylin–
eosin and Giemsa stains. Metaplasia type was visualized using 
Periodic acid-Schiff (PAS) and Alcian Blue staining (PAS–Alcian 
blue stain). The number, location, and size of adenomatous 
polyps and the presence of dysplasia were also assessed in the 
study group. The location of colonic polyps was documented 
and classified as proximal colon, distal colon, or pan-colonic. 
The proximal colon included the transverse colon, hepatic flex-
ure, ascending colon, and cecum. The distal colon included the 
rectum, sigmoid, descending colon, and splenic flexure. Pol-
yps located in both were classified as pan-colonic. Advanced 
adenomas were defined as large adenomas (≥10 mm in size) 
or adenomas with histopathologic findings of villous or high-
grade dysplasia.
The study was approved by the local Ethics Committee of 
Başkent University.
Statistical analysis
Data were analyzed using SPSS Statistics for Windows, Version 
17.0. (SPSS Inc.; Chicago, IL, USA). The odds ratio (OR) was calcu-
lated to determine the association of two binary variables. Fur-
thermore, logistic regression analysis was utilized to evaluate 
the relationships between risk factors of the binary variables; 
ORs were used to interpret these results. Differences between 
the means of two continuous variables were analyzed using t-
tests, and differences between two proportions were analyzed 
using z-tests. Statistical analyses were performed using R (3.1.2). 
P values less than 0.05 were considered statistically significant 
in all analyses.
RESULTS
A total of 760 adult patients, 400 with colonic adenomatous 
polyps (study group) and 360 without polyps (control group), 
were included. Among the 400 patients with colonic polyps, 
205 were men and 195 were women. The control group com-
prised 360 patients; 145 were men and 215 were women. OR 
was as 0.64 (p<0.05). Men had a 1.5-fold higher risk of colonic 
polyps than women (Table 1).
The mean overall age of the 760 patients was 57 years; the 
mean age for the study and control groups were 58 years 
(30–87 years) and 56 years (21–93 years), respectively. T-test 
analysis of these age differences was not statistically significant 
(p>0.05).
Demographic data and the presence of H. pylori infection, gas-
tric atrophy, or IM were first analyzed for all 760 patients. Pa-
tients were classified as younger than 50 years or 50 years and 
older. Associations of risk factors (demographic data and pres-
ence of colonic polyps) with gastric IM, gastric atrophy, and H. 
pylori infection were analyzed by multiple logistic regression 
analyses (Table 2 and 3).
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                Gender 
 Male  Female  Total
Patients with colonic polyps (study group) 205 195 400
Patients without colonic polyps (control group) 145 215 360
Total 350 410 760
Table 1. Gender characteristics
                     Metaplasia                   Atrophy
Risk factor Odds ratio p Odds ratio p
≥50 years of age 2.76 <0.05 2.95  <0.05
Male gender 1.45 <0.05 1.50  <0.05
Presence of colonic polyps 1.42 <0.05 1.24  >0.05
IM: intestinal metaplasia
Table 2. Multiple logistic regression analysis for risk factors associated with 
gastric IM or atrophy
As shown in Table 2, the risk of developing gastric IM in patients 
aged ≥50 years was 2.76-fold higher than those aged <50 years 
(OR=2.76, p<0.05). The risk of developing gastric IM in men was 
1.45-fold higher than in women (OR=1.45, p<0.05). In addition, 
the risk of gastric IM in the study group was 1.42-fold higher 
than that in the control group (OR=1.42, p<0.05).
The risk of gastric atrophy in patients aged ≥50 years was 2.95-
fold higher than those aged <50 years (OR=2.95, p<0.05) (Table 
2). Similarly, the risk of developing gastric atrophy was 1.5-fold 
higher in men than in women (OR=1.50, p<0.05). However, the 
risk of developing gastric atrophy did not significantly differ be-
tween the control and study groups (OR=1.24, p>0.05).
Unlike gastric IM and atrophy, the rate of H. pylori infec-
tion in patients aged <50 years was 1.15-fold higher than in 
those aged ≥50 years (Table 3). However, this difference was 
not statistically significant (OR=1.15, p>0.05). H. pylori infec-
tion was 1.30-fold more common among men than among 
women; this risk difference was also not statistically significant 
(OR=1.30, p>0.05). The risk of the presence of H. pylori infection 
in the study group was 1.07-fold higher than that in the control 
group (OR=1.33, p<0.05).
Risk factors that might be associated with IM and H. pylori in-
fection in the study group were also examined. The results 
showed that the risk of developing gastric IM in patients with 
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Figure 1. The scheme depicting patient selection
colonic polyps aged ≥50 years was 3.35-fold higher than in 
those aged <50 years (OR=3.35, p<0.05) (Table 4). Although 
the risk of developing IM was 1.47-fold higher in men with co-
lonic polyps than women, the difference was not statistically 
significant (OR=1.47, p>0.05). The location or number of co-
lonic polyps did not play a significant role in the risk of gastric 
IM in the study group (OR=1.04, p>0.05 and OR=1.13, p>0.05, 
respectively). The presence of advanced adenoma was associ-
ated with a significantly increased risk of gastric IM (OR=1.27, 
p<0.05).
The presence of H. pylori infection was higher only in patients 
with high-grade colonic polyp dysplasia (OR=1.32, p<0.05) 
(Table 5). Patient age or gender and the location and number 
of colonic polyps were not significantly associated with gastric 
dysplasia grade (OR=1.00, p>0.05; OR=1.30, p>0.05; OR=1.16, 
p>0.05; OR=1.05, p>0.05; OR=1.06, p>0.05, respectively).
Table 6 shows the number of the patients in both groups with 
incomplete and complete IM. According to the z-test for pro-
portions of two samples, there was no statistically significant 
difference between the proportions of incomplete IM in these 
groups (p>0.05).
DISCUSSION
IM is the conversion of the superficial epithelium of oxyntic and 
antral mucosa into the intestinal epithelium. H. pylori infection 
is the main factor for the development of gastric IM. H. pylori 
infection can result in the development of chronic gastritis, 
glandular atrophy, IM, and dysplasia before carcinoma devel-
ops. Colonic polyps may be precursors of CRC through an ad-
enoma-carcinoma sequence. The present study from a tertiary 
hospital investigated the association of IM with colonic polyps 
that may be precursors of malignancies in the gastrointestinal 
tract, and also determined if there were signs that might rec-
ommend gastroscopy in patients with polyps detected during 
colonoscopy. Our data showed that the risk of having gastric 
IM in patients with colonic polyps was than that in patients 
without colonic polyps (OR=1.42, p<0.05).
The risk of histopathologically determined H. pylori infection in 
the study group was higher than in the control group in this 
study, which is consistent with other reports (OR=1.33, p<0.05) 
(7-10). There was no statistical difference between the mean 
ages of the study and control groups in this study, but statis-
tically more men had colonic polyps. This data showed that 
male patients had 1.5 times the risk of colonic polyps com-
pared to female patients (OR=0.64, p<0.05). The increased rate 
of colonic polyps in men was also consistent with the literature 
(11,12). The analysis indicated that the risk of developing gas-
tric IM in patients ≥50 years of age was 2.76 times higher than 
in patients <50 years (OR=2.76, p<0.05). The risk of developing 
gastric IM was 1.45 times higher in men than in women. This 
finding was also consistent with other reports (13).
Among common factors, H. pylori infection is most often as-
sociated with the pathogenesis of gastric IM and colonic pol-
yps. The association of colonic polyps and CRC with H. pylori 
infection has been reported in many meta-analyses from 2006 
to 2013. These previous studies have suggested that H. pylori 
infection leads to a 1.4–1.6-fold increased risk of colonic ade-
noma or CRC. H. pylori infection in patients with CRC or colonic 
polyps detected by serology and 13C-urea breath tests (7-10). 
Recent publications have used immune-histochemical meth-
ods to detect H. pylori in colonic polyps and CRC tissues (14).
H. pylori-induced gastritis, atrophy, metaplasia, and cancer cas-
cade in the gastric mucosa is now well accepted. Atrophy and 
hyper-gastrinemia developing during this cascade can have a 
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Risk factor Odds ratio p
<50 years of age 1.15 >0.05
Male gender 1.30 >0.05
Presence of colonic polyps 1.33 <0.05
Table 3. Multiple logistic regression analysis for risk factors associated with 
H. pylori infection
Risk factor Odds ratio p
≥50 years of age 3.35 <0.05
Male gender 1.47 >0.05
Location of colonic polyps 1.04 >0.05
Number of colonic polyps 1.13 >0.05
Presence of advanced adenoma 1.27 <0.05
Table 4. Multiple logistic regression analysis for risk factors associated with 
gastric intestinal metaplasia
Risk factor Odds ratio p
≥50 years of age 1.00 >0.05
Male gender 1.30 >0.05
Location of colonic polyps 1.16 >0.05
Number of colonic polyps 1.05 >0.05
Presence of advanced adenoma 1.32 <0.05
Grade of gastric dysplasia 1.06 >0.05
Table 5. Multiple logistic regression analysis for H. pylori infection-
associated risk factors in the study group
                         IM type 
 Incomplete Complete Total
Patients with colonic polyps 45 60 105
Patients without colonic polyps 25 47 72
Total 70 107 177
IM: intestinal metaplasia
Table 6. Number of patients according to intestinal metaplasia type
trophic effect on colonic mucosa. They can also contribute to 
the development of carcinogenicity, with a direct effect on the 
colonic mucosa. Most hypotheses about the effects of H. pylori 
infection effect on colonic polyps and CRC etiology are based on 
hypergastrinemia. Gastrin is the main hormone responsible for 
stimulation of gastric acid secretion. Additionally, gastrin and its 
derivatives exert proliferative and anti-apoptotic effects on the 
early stages of several types of cell tumors. This peptide structure 
hormone is synthesized as pre-pro-gastrin in the antral G cells. 
It is first converted to pro-gastrin by peptidase, and then con-
verted to its biologically active amidated forms. Related to CRC, 
it is believed that gastrin has endocrine and paracrine effects on 
colorectal cells and also has trophic and anti-apoptotic proper-
ties. Research in recent years has indicated that pro-gastrin, pre-
viously thought to be an inactive form, is responsible for the car-
cinogenic effects. Furthermore, gastrin synthesized from tumor 
tissue also may have an autocrine effect. Increased gastrin levels 
are correlated with anti-apoptotic bcl-2 activity and increased 
tumorigenic and mutagenic cyclooxygenase-2 levels (15-18).
The second hypothesis regarding the effect of chronic H. pylori 
gastritis on colonic mucosa is that the infection results in enter-
ic infections and bacterial overgrowth due to decreased gas-
tric acid secretion. The impairment of gastric protein digestion 
due to hypochlorhydria and the fermentation of unabsorbed 
nutrients reaching the colon with excessive bacterial load may 
contribute to the development of CRC (19). In addition, the 
presence of H. pylori infection may be an indication of exposure 
to poor sanitation standards and frequent intestinal infections 
during childhood (20).
There is no consensus about the localization of colonic polyps 
and CRC in the presence of H. pylori infections. Although some 
literature reports suggest that colorectal adenomas are fre-
quently observed in the left colon, other reports indicate that 
they are more often located in the proximal colon (21-23). These 
studies report that localization differences could be explained 
by chromosomal abnormalities during the development of left 
and right CRC (4). However, a study by Sonnenberg et al. (20) on 
156000 patients did not report an association of the presence 
of H. pylori infection with the localization of colonic polyps or 
CRC. Similarly, our study did not find an association of H. pylori 
infection with the location of colonic polyps and gastric IM. The 
number of polyps did not play a statistically significant role in 
the risk of developing gastric IM in the study group (OR=1.04, 
p>0.05 and OR=1.13, p>0.05, respectively). However, increas-
ing polyp dysplasia grades were significantly associated with 
an increased risk of gastric IM (OR=1.27, p<0.05).
After observing that colonic polyps were more frequent in pa-
tients with IM, we evaluated the association of gastric IM type 
with colonic polyps. Although there are reports that gastric 
cancer more frequently develops on a background of incom-
plete IM, several studies have also reported the opposite (24). 
In our study, the association of the presence of colonic polyps 
with IM type was evaluated in biopsies stained with PAS-Alcian 
blue, but a statistically significant difference was not observed 
in the prevalence of incomplete or complete IM in the study 
and control groups.
Several publications have reported that atrophic gastritis is not 
associated with increased CRC risk (25,26). Our study also found 
no statistically significant association in the risks of develop-
ing gastric atrophy in either the study or the control group 
(OR=1.24, p>0.05). Previous studies have not reported signifi-
cant associations of colonic polyps with gastric atrophy. To our 
knowledge, there are no other reports on the association of 
colonic polyps with gastric IM. We believe that this positive as-
sociation is related to the long-term course of IM. These data 
show that the frequent coexistence of colonic polyps and gas-
tric IM may not be explained only by H. pylori infection and hy-
pergastrinemic atrophic gastritis. A study by Fujimori et al. (27) 
in Japan reported a steadily decreasing prevalence of H. pylori 
infection, while the prevalence of CRC increased. Other factors 
besides H. pylori infection might increase the rate of CRC; how-
ever, further investigations are required.
This study had several limitations. Due its retrospective nature, 
all factors associated with gastrointestinal malignancies could 
not be further explored. The evaluation of smoking or nutri-
tional habits, body mass index, family history of gastrointesti-
nal malignancy, socioeconomic status, and use of aspirin and 
Non-Steroidal Anti Inflammatory Drugs (NSAIDs) might offer a 
better understanding of the etiopathogenesis of gastrointesti-
nal malignancies. Additionally, previous antibiotic and proton 
pump inhibitor use should be evaluated. Insufficient corpus 
biopsy specimens prevented the classification of atrophy and 
metaplasia. We used routine biopsies, including antrum and 
incisura samples. Further studies including multiple gastric bi-
opsies are necessary.
In conclusion, this study showed that the rate of gastric IM in-
creases in the presence of colonic polyps. The risk of gastric IM 
increased with higher grades of polyp dysplasia. No association 
of gastric IM type with colonic polyps. Prospective multicenter 
studies may better explain the etiopathogenesis and associa-
tion of the presence of gastric IM with colonic polyps.
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